Marksans Pharma is one of the finest pharma company today & offering services in several areas. The share prices of this pharma company rallied around 15% intraday Monday after the company registered a healthy profit growth in the June quarter of 2018.

The consolidated profit during the June quarter increased rapidly by 72.6% to INR 24.9 crore, backed by operational business growth & stable revenue. The Q1 revenue increased 6.4% to INR 235.5 Cr. Year-on-Year on operations growth across the board.

On 06 August 2018 at 15:58 IST, the stock price was at INR 33.50, up 4.25 or 14.53% on the BSE.

About Marksans Pharma:

Marsans Pharma was started back by Mark Saldanha and a Mumbai-based pharmaceutical company offering the services worldwide. The strength of the company lies in R&D, manufacturing & marketing of pharmaceutical formulations. The current market value stands at INR 1,375.29 Crore.